CLB FY 2011 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2011 Earnings

Reported February 15, 2012

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2011	Prior Q	FY 2010	QoQ Change	YoY Change
Revenue	$908M	—	$795M	—	14.2%
Op. Income	$251M	—	$227M	—	10.5%
Gross Margin	34.6%	—	35.3%	—	-0.7pp
Net Margin	20.3%	—	18.2%	—	2.1pp
EPS (Diluted)	$3.82	—	$3.00	—	27.3%
Free Cash Flow	$174M	—	$178M	—	-2.3%

Revenue Flow

Item	Amount
REVENUE	$908M
Cost of Revenue	$593M
GROSS PROFIT	$314M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$41M
Other Expenses	$22M
Operating Expenses	$64M
Cost & Expenses	$657M
OPERATING INCOME	$251M
Interest Income	$138.0K
Interest Expense	$11M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$239M
Income Tax Expense	$54M
Net Income from Continuing Ops	$185M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$185M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$185M
D&A	$23M
EBIT	$250M
EBITDA	$271M
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$908M
Cost of Revenue	$593M
GROSS PROFIT	$314M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$41M
Other Expenses	$22M
Operating Expenses	$64M
Cost & Expenses	$657M
OPERATING INCOME	$251M
Interest Income	$138.0K
Interest Expense	$11M
Other Income/Expenses	-$12M
INCOME BEFORE TAX	$239M
Income Tax Expense	$54M
Net Income from Continuing Ops	$185M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$185M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$185M
D&A	$23M
EBIT	$250M
EBITDA	$271M
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$185M
Depreciation & Amortization	$23M
Stock-Based Compensation	$17M
Deferred Income Tax	-$7M
Other Non-Cash Items	$7M
Change in Working Capital	-$21M
OPERATING CASH FLOW	$204M
Capital Expenditure	-$30M
Acquisitions (Net)	-$19M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$33M
NET CASH FROM INVESTING	-$52M
Net Debt Issuance	$69M
Common Stock Repurchased	-$62M
Common Dividends Paid	-$46M
Other Financing Activities	-$218M
NET CASH FROM FINANCING	-$257M
FREE CASH FLOW	$174M
Net Change in Cash	-$105M

Balance Sheet

Item	Amount
Cash & Equivalents	$29M
Short-Term Investments	$0
Net Receivables	$178M
Inventory	$53M
Other Current Assets	$12M
TOTAL CURRENT ASSETS	$281M
PP&E (Net)	$115M
Goodwill	$163M
Intangible Assets	$8M
Long-Term Investments	$0
Tax Assets	$14M
Other Non-Current Assets	$24M
TOTAL NON-CURRENT ASSETS	$324M
TOTAL ASSETS	$605M
Account Payables	$58M
Short-Term Debt	$2M
Deferred Revenue	$19M
Other Current Liabilities	$24M
TOTAL CURRENT LIABILITIES	$137M
Long-Term Debt	$223M
Deferred Revenue NC	$24M
Deferred Tax Liabilities	$6M
Other Non-Current Liabilities	$33M
TOTAL NON-CURRENT LIABILITIES	$286M
TOTAL LIABILITIES	$423M
Common Stock	$1M
Additional Paid-In Capital	$2M
Retained Earnings	$284M
Treasury Stock	-$107M
Accum. Other Comp. Income	-$2M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$178M
Minority Interest	$4M
TOTAL EQUITY	$182M
TOTAL LIABILITIES & EQUITY	$605M
Total Debt	$225M
Net Debt	$196M